Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease.
about
Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspectiveInteractions between muscle stem cells, mesenchymal-derived cells and immune cells in muscle homeostasis, regeneration and diseaseAlive and well? Exploring disease by studying lifespan.TNF-α and IGF1 modify the microRNA signature in skeletal muscle cell differentiationPreserved skeletal muscle protein anabolic response to acute exercise and protein intake in well-treated rheumatoid arthritis patientsSmoking and Early COPD as Independent Predictors of Body Composition, Exercise Capacity, and Health Status.TWEAK/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction.Structural alterations of skeletal muscle in copd.Sarcopenia in solid organ transplantation.Phase II drugs that are currently in development for the treatment of cachexia.Ginsenoside Rg1 prevents starvation-induced muscle protein degradation via regulation of AKT/mTOR/FoxO signaling in C2C12 myotubesClinical and radiological outcome following pneumothorax after endoscopic lung volume reduction with valves.Chronic kidney disease: A likely underestimated component of multimorbidity in older patients with chronic obstructive pulmonary disease.Nutritional status and its effects on muscle wasting in patients with chronic heart failure: insights from Studies Investigating Co-morbidities Aggravating Heart Failure.Oxidative and proteolysis-related parameters of skeletal muscle from hamsters with experimental pulmonary emphysema: a comparison between papain and elastase induction.Long-term cigarette smoke exposure inhibits histone deacetylase 2 expression and enhances the nuclear factor-κB activation in skeletal muscle of mice.Defining COPD-Related Comorbidities, 2004-2014.DNA damage and repair capacity in lymphocyte of chronic obstructive pulmonary diseases patients during physical exercise with oxygen supplementation.Differential regulation of muscle protein turnover in response to emphysema and acute pulmonary inflammation.Echo intensity of the rectus femoris in stable COPD patients.Redox-Dependent Calpain Signaling in Airway and Pulmonary Vascular Remodeling in COPD.Tumor necrosis factor-like weak inducer of apoptosis regulates quadriceps muscle atrophy and fiber-type alteration in a rat model of chronic obstructive pulmonary disease.Relationship between PPARα mRNA expression and mitochondrial respiratory function and ultrastructure of the skeletal muscle of patients with COPD.The sarcopenia index: A novel measure of muscle mass in lung transplant candidates.The minimal important difference for target lobe volume reduction after endoscopic valve therapy.Network modules uncover mechanisms of skeletal muscle dysfunction in COPD patients.Repetitive TLR-3 activation in the lung induces skeletal muscle adaptations and cachexia.Oxidative stress and damage to erythrocytes in patients with chronic obstructive pulmonary disease--changes in ATPase and acetylcholinesterase activity.Molecular Changes in Sub-lesional Muscle Following Acute Phase of Spinal Cord Injury.Twenty-eight days of exposure to 3454 m increases mitochondrial volume density in human skeletal muscle.Association between sarcopenia and metabolic syndrome in chronic obstructive pulmonary disease: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2011.Pulmonary inflammation-induced loss and subsequent recovery of skeletal muscle mass require functional poly-ubiquitin conjugation.
P2860
Q26749418-DAA4D034-EA13-4762-88A1-46253C52B783Q26800192-38E65020-32DB-4501-8F11-DD79FB537957Q34618596-B7A9F928-4F69-474C-9407-47E6B242B9A0Q35077416-0D8615CA-C8B5-4CBC-86A1-F4BAB94E85B6Q36093378-F25BEBAE-46EC-4CAA-9B50-B5E3B612B672Q36162963-8DF5E60A-E98F-49DE-8079-60779BE22776Q37516544-2FC8F01D-7C23-412F-8F0C-6FC0D68ED95AQ37644954-5FDB597C-98FA-4BCB-93C1-6FF734980167Q38188425-B7D63B9B-7A89-495D-9C8E-34215E40EF0EQ38233278-F94E9020-B7B6-41B5-89C2-D8D8B45B8E5BQ38638011-95091904-0F5D-48DE-B662-575589924BEAQ39085675-2BDE3D46-5079-4E2B-8A91-9888824A5DBCQ39309691-F531768E-BE96-484E-9526-C3278B1F7F50Q40472605-56650D57-B24E-4DD5-8CCC-EFCCE77195B9Q40808876-66CAEAF0-B026-4DC5-907F-61DA247F4164Q41345037-BBEA6860-2F2A-4FF3-9654-E68C29602C46Q41443181-93327E5F-F190-4C4D-AEBB-9B27FB19A0DDQ41854534-A2AB989B-201E-42AA-8122-AB882B2775D0Q42289835-D73092A9-B07D-4076-86EC-2691BA55C2E5Q42673163-F03A6CE7-A4EB-4222-AF02-3ABB71044281Q46280869-BE60556C-7438-4423-8BA3-8C8D7C299C67Q47148974-AA4E0BB0-7DD1-471F-AE2E-52DEFB58D88DQ47833542-63A21E13-A0CD-406D-B281-E37ECFFB64B9Q48351866-C043E3E8-36B6-4A0F-A0F5-55D72CEE2A73Q49465569-2363A61B-5990-4806-9A87-746F50ABE84FQ49795543-36449991-DDB4-4C9A-85FA-0EAB7C3E5E14Q49922922-888616A3-4D27-4C16-AD11-A20FD6EA9D06Q50437145-69136107-ADB9-41FC-931D-C36282059D9CQ50438187-AF791DC6-9BFD-4881-A9B2-1A03F2195F78Q50564221-C41FB867-E735-4BE3-B0C4-07D127D8F42FQ51135108-D884C121-58B6-4C23-B1C4-BFCE38F60203Q55033522-5FAC6268-DF13-4845-A969-5AF7A9A7BF49
P2860
Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Triggers and mechanisms of ske ...... obstructive pulmonary disease.
@en
type
label
Triggers and mechanisms of ske ...... obstructive pulmonary disease.
@en
prefLabel
Triggers and mechanisms of ske ...... obstructive pulmonary disease.
@en
P2093
P1476
Triggers and mechanisms of ske ...... obstructive pulmonary disease
@en
P2093
A H V Remels
A M W J Schols
R C J Langen
P304
P356
10.1016/J.BIOCEL.2013.06.015
P577
2013-07-01T00:00:00Z